T2 Biosystems Operating Income

T2 Biosystems (TTOO) currently reports a operating income of $-42M as of September 2024. That compares with $-50M in the prior-year period — up 16.5% year over year. Use the charts on this page to explore T2 Biosystems's operating income history and peer comparisons.

T2 Biosystems's operating income increased from $-50M to $-42M — a 16.5% year-over-year increase (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

T2 Biosystems reported $-42M in operating income as of September 2024. That compares with $-50M in the prior-year period — up 16.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-42M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for T2 Biosystems, and consider following TTOO for alerts when major investors trade the stock.

T2 Biosystems is classified in the Industrials sector. On operating income, it currently shows $-42M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Industrials are usually more informative than comparing TTOO with unrelated industries.